Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

2019 Drug Launches: New Specialty And Rare Disease Blockbusters Take Shape

Dec 31 2019

• By Jessica Merrill

Rocket takes off in the starry sky. Spaceship begins the mission. Space shuttle taking off on a Planet Mars. — Scrip looks back at the commercial winners that launched in 2019

Related Content

AbbVie’s Humira Succession Plan Begins Taking Shape With Skyrizi US Approval

Apr 24 2019

2018 Saw Record Launches, But No Big Splash

Apr 05 2019

It's Official: Novartis SMA Gene Therapy Zolgensma Is World's Most Expensive Drug

May 24 2019

Pfizer Vyndaqel Launch Surprises With An Early Burst Out Of The Gate

Oct 29 2019

Related Companies

Novartis AG

Pfizer Inc.

Sanofi

Ablynx N.V.

AbbVie Inc.

Johnson & Johnson

Eli Lilly and Company

Roche Holding AG

Sage Therapeutics, Inc.

Regeneron Pharmaceuticals, Inc.

GSK plc

AstraZeneca PLC

Additional Topics

Launches Market Access Pricing Strategies Rare Diseases Commercial BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.